Lucid Diagnostics Inc. Share Price
NASDAQ: LUCD | Micro CapLucid Diagnostics Inc. Stock Performance
Lucid Diagnostics Inc. Share Price Today
As of 29 October 2026, Lucid Diagnostics Inc.'s share price is $0.45. The stock opened at $0.41, compared to its previous close of $0.41. During today's trading session, Lucid Diagnostics Inc.'s share price traded between $0.40 and $0.45, with an average price of $0.43. Over the past 52 weeks, the stock has recorded a high of $1.62 and a low of $0.30. In terms of performance, Lucid Diagnostics Inc.'s share price has declined by 58.21% over the last six months and is down 62.74% on a year-on-year basis.
Lucid Diagnostics Inc. Share Price Chart
Lucid Diagnostics Inc. Quarterly Profit & Loss
All figures in USD
Lucid Diagnostics Inc. Annual Profit & Loss
All figures in USD
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Lucid Diagnostics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.71 | $0.43 | -42.71% |
Sep 2026 | $0.97 | $0.75 | -23.61% |
Aug 2026 | $0.90 | $0.99 | +13.06% |
Jul 2026 | $1.08 | $0.87 | -18.03% |
Jun 2026 | $1.03 | $1.06 | +3.40% |
May 2026 | $1.08 | $1.03 | -3.74% |
Apr 2026 | $1.16 | $1.07 | -6.96% |
Mar 2026 | $1.41 | $1.15 | -20.69% |
Feb 2026 | $1.18 | $1.45 | +22.88% |
Jan 2026 | $1.08 | $1.18 | +8.76% |
Dec 2025 | $1.06 | $1.08 | +2.36% |
Nov 2025 | $1.21 | $1.06 | -11.67% |